Last reviewed · How we verify
Losartan Potassium and Hydrochlorothiazide Tablets
Losartan Potassium and Hydrochlorothiazide Tablets is a Small molecule drug developed by Torrent Pharmaceuticals Limited. It is currently in Phase 1 development.
At a glance
| Generic name | Losartan Potassium and Hydrochlorothiazide Tablets |
|---|---|
| Sponsor | Torrent Pharmaceuticals Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients (PHASE4)
- Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension (PHASE3)
- A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327) (PHASE3)
- A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3) (PHASE4)
- MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352) (PHASE3)
- A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351) (PHASE3)
- Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment (PHASE3)
- Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Losartan Potassium and Hydrochlorothiazide Tablets CI brief — competitive landscape report
- Losartan Potassium and Hydrochlorothiazide Tablets updates RSS · CI watch RSS
- Torrent Pharmaceuticals Limited portfolio CI
Frequently asked questions about Losartan Potassium and Hydrochlorothiazide Tablets
What is Losartan Potassium and Hydrochlorothiazide Tablets?
Losartan Potassium and Hydrochlorothiazide Tablets is a Small molecule drug developed by Torrent Pharmaceuticals Limited.
Who makes Losartan Potassium and Hydrochlorothiazide Tablets?
Losartan Potassium and Hydrochlorothiazide Tablets is developed by Torrent Pharmaceuticals Limited (see full Torrent Pharmaceuticals Limited pipeline at /company/torrent-pharmaceuticals-limited).
What development phase is Losartan Potassium and Hydrochlorothiazide Tablets in?
Losartan Potassium and Hydrochlorothiazide Tablets is in Phase 1.